文献速递骨质疏松与代谢性骨病

欧洲初级保健中骨折风险患者的骨质疏松治疗缺口:多国横断面观察研究

The osteoporosis treatment gap in patients at risk of fracture in European primary care: a multi-country cross-sectional observational study.
PubMed 文献 · Osteoporos Int · 2020-08-23

该研究在8个欧洲国家纳入3798名70岁及以上就诊于全科医生的女性,采用骨折史、FRAX阈值和T-score≤-2.5定义骨折风险增高。结果发现55%符合至少一项风险增高定义,治疗缺口为74.6%(各国从53%到91%),且骨质疏松诊断率低(21.2%),诊断与治疗缺口较低相关(绝对降低63%)。

要点

  • 在8个欧洲国家70岁及以上女性中,55%符合至少一项骨折风险增高定义。
  • 骨折风险增高者的治疗缺口为74.6%,各国从53%(爱尔兰)到91%(德国)不等。
  • 仅21.2%患者有骨质疏松诊断记录,有诊断者治疗缺口绝对降低63%。

核心结论

  • 欧洲常规初级保健中70岁及以上骨折风险增高女性存在较大治疗缺口,该缺口似乎与骨质疏松诊断率低有关。

研究设计与样本

  • 横断面观察研究,在8个欧洲国家收集70岁及以上就诊于全科医生的女性数据,共纳入3798名患者。

主要发现

  • 3798名入组患者的中位10年骨折概率(未使用骨密度)为髋部7.2%、主要骨质疏松性骨折16.6%。
  • 2077名女性(55%)符合一项或多项骨折风险增高定义:1200名有既往骨折,1814名超过FRAX阈值,318名T-score≤-2.5(仅944名接受了双能X线吸收测定法扫描)。
  • 骨折风险增高者的中位10年髋部和主要骨质疏松性骨折概率分别为11.2%和22.8%,而判定为无风险者分别为4.1%和11.5%。
  • 804名患者(21.2%)记录了骨质疏松诊断,其中大多数(79.7%)为骨折风险增高者。
  • 治疗缺口为74.6%,各国从爱尔兰的53%到德国的91%不等;有骨质疏松诊断者较无诊断者治疗缺口绝对降低63%。

关键数值与推荐

  • 骨折风险增高定义:使用骨折史、10年骨折概率超过各国特定FRAX阈值、T-score≤-2.5。
  • 治疗缺口定义为骨折风险增高者中未接受任何骨质疏松药物治疗的比例,结果为74.6%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: This study in 8 countries across Europe found that about 75% of elderly women seen in primary care who were at high risk of osteoporosis-related fractures were not receiving appropriate medication. Lack of osteoporosis diagnosis appeared to be an important contributing factor. INTRODUCTION: Treatment rates in osteoporosis are documented to be low. We wished to assess the osteoporosis treatment gap in women ≥ 70 years in routine primary care across Europe. METHODS: This cross-sectional observational study in 8 European countries collected data from women 70 years or older visiting their general practitioner. The primary outcome was treatment gap: the proportion who were not receiving any osteoporosis medication among those at increased risk of fragility fracture (using history of fracture, 10-year probability of fracture above country-specific Fracture Risk Assessment Tool [FRAX] thresholds, T-score ≤ - 2.5). RESULTS: Median 10-year probability of fracture (without bone mineral density [BMD]) for the 3798 enrolled patients was 7.2% (hip) and 16.6% (major osteoporotic). Overall, 2077 women (55%) met one or more definitions for increased risk of fragility fracture: 1200 had a prior fracture, 1814 exceeded the FRAX threshold, and 318 had a T-score ≤ - 2.5 (only 944 received a dual-energy x-ray absorptiometry [DXA] scan). In those at increased fracture risk, the median 10-year probability of hip and major osteoporotic fracture was 11.2% and 22.8%, vs 4.1% and 11.5% in those deemed not at risk. An osteoporosis diagnosis was recorded in 804 patients (21.2%); most (79.7%) of these were at increased fracture risk. The treatment gap was 74.6%, varying from 53% in Ireland to 91% in Germany. Patients with an osteoporosis diagnosis were found to have a lower treatment gap than those without a diagnosis, with an absolute reduction of 63%. CONCLUSIONS: There is a large treatment gap in women aged ≥ 70 years at increased risk of fragility fracture in routine primary care across Europe. The gap appears to be related to a low rate of osteoporosis diagnosis.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. McCloskey E, Rathi J, Heijmans S, et al. The osteoporosis treatment gap in patients at risk of fracture in European primary care: a multi-country cross-sectional observational study. Osteoporos Int. 2020. PMID: 32829471. doi:10.1007/s00198-020-05557-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。